The Food and Drug Administration on Wednesday approved a new immunotherapy drug from Roche to treat bladder cancer, a form of cancer for which there have been no significant new medicines in years.
Read Full Article »
FDA OKs Immunotherapy Drug for Bladder Cancer
Comment
